Literature DB >> 15708911

Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab.

F Broussais, M Kawashima, H Marotte, P Miossec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15708911      PMCID： PMC1755413          DOI： 10.1136/ard.2004.021378

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  TNF-alpha inhibitors and leukaemia: international pharmacovigilance reports.

Authors:  Ronald H B Meyboom; Kristina Star; Jenny Bate; Ruth Savage; I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Infliximab therapy in hematologic malignancies: handle with care.

Authors:  Fabio Stagno; Paolo Vigneri; Alessandra Cupri; Silvia Rita Vitale; Francesco Di Raimondo
Journal:  Haematologica       Date:  2012-08       Impact factor: 9.941

3.  Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn's disease accompanied by chronic myeloid leukemia.

Authors:  Tsutomu Mizoshita; Satoshi Tanida; Shigeru Kusumoto; Keiji Ozeki; Hironobu Tsukamoto; Masahide Ebi; Yoshinori Mori; Hiromi Kataoka; Takeshi Kamiya; Takashi Joh
Journal:  Clin J Gastroenterol       Date:  2012-06-10

4.  Current Perspectives on the Role of TNF in Hematopoiesis Using Mice With Humanization of TNF/LT System.

Authors:  Violetta S Gogoleva; Kamar-Sulu N Atretkhany; Arina P Dygay; Taisiya R Yurakova; Marina S Drutskaya; Sergei A Nedospasov
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.